NAVGENVYS

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 May 2025 filing date already counts against anyone who files later.

Record

Serial number

99172007

Mark type

Stylized text

Filed

06 May 2025

Published for opposition

21 Oct 2025

Attorney of record

William R. Samuels

Goods and services

• Class 005 — Pharmaceuticals: Biological preparations for medical use in the treatment of genetic diseases and disorders, and muscle disorders, namely, Duchenne muscular dystrophy; Pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders, and muscle disorders, namely, Duchenne muscular dystrophy; Clinical medical reagents for use in gene therapy; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of genetic diseases and disorders, namely, Duchenne muscular dystrophy; Gene therapy preparation for medical use containing genetic materials for sustained protein expression, namely, microdystrophin expression

Owner

• REGENXBIO Inc., Rockville, MD, US
• REGENXBIO Inc., Rockville, MD, US

Prosecution history

• 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 21 Oct 2025 — PUBLISHED FOR OPPOSITION
• 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 24 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Sept 2025 — ASSIGNED TO EXAMINER
• 06 May 2025 — APPLICATION FILING RECEIPT MAILED
• 06 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 06 May 2025 — NEW APPLICATION ENTERED